Low-dose Buccal Buprenorphine: Relative Abuse Potential and Analgesia — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Low-dose Buccal Buprenorphine: Relative Abuse Potential and Analgesia — Stella

Recruiting

Back to Analgesia trials

Phase 4 — Post-approval study. The treatment has been approved, but researchers continue monitoring it in a large population over time.

Trial locations(1 site)

United States

Vanderbilt University Medical Center, Nashville, Tennessee

Key details

Phase

Post-approval study

Sponsor

Vanderbilt University Medical Center

Collaborators

National Institute on Drug Abuse (NIDA)

Enrollment target

~120 participants

Started

October 2023

Primary completion

January 2028

Age range

18 Years – 65 Years

Last updated January 2026

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Follow this trial

Get notified in plain English when this trial's status changes. No account required.

View full record on ClinicalTrials.gov